WCLC 2025: Lung Cancer Screening and Early Results from the Danish PLUS Trial

In this MEDtalk, Senior Consultant Michael Stenger from Odense University Hospital presents key findings from his WCLC 2025 presentation on lung cancer screening. Drawing on international evidence and early data from the Danish PLUS trial, he highlights the impact of low-dose CT in reducing mortality and detecting early-stage cancers, while addressing implementation challenges such as false positives and health equity.